Form D · Pharmaceuticals
CanaQuest Medical Corp.
Mississauga, A6 · CIK 0001607679
Offering snapshot reported Oct 26, 2022 · SEC filing
- Reported sold
- Yet to sell Offering amount: $2M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 26, 2022 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jun 11, 2014 | Initial | $30,710 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-462821
Subject to future contingencies
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Marquee Equity | None | |
| OCMX | None | |
| Keiretsu Forum Canada | None |
Source: Form D, filed Oct 26, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ross Eastley | Director, Executive |
| Gordon Ross Eastley | Director, Executive |
| Sandra Elsley | Executive |
| Cameron Mc Donald | Director |
| Paul Byron Ramsay | Director, Executive |
| Richard Rusiniak | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
Unit 37 4120 Ridgeway Drive
Mississauga, A6, L5L 5S9
Mississauga, A6, L5L 5S9